Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Prueba de los efectos del ejercicio en la neuropatía periférica inducida por quimioterapia (CIPN)

24 de septiembre de 2026 actualizado por: Po-Ju Lin, University of Rochester NCORP Research Base

Ensayo multicéntrico aleatorizado controlado de fase II de ejercicio para tratar la neuropatía periférica inducida por quimioterapia (CIPN)

This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.

Descripción general del estudio

Estado

Activo, no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

PRIMARY OBJECTIVE:

I. Assess the preliminary efficacy of exercise versus (vs.) standard care for treating CIPN (via patient-reported CIPN-20 total score).

SECONDARY OBJECTIVES:

I. Assess the preliminary efficacy of exercise vs. standard care on individual symptoms of CIPN (via CIPN Symptom Inventory; i.e., numbness, tingling, burning/shooting pain, and cramping in the hands and feet).

II. Assess the preliminary efficacy of exercise vs. standard care on a clinical test of CIPN symptoms (via the tactile sensitivity in the fingers and toes).

III. Assess the effects of exercise vs. standard care on two possible CIPN mechanisms, namely interoception (via Multidimensional Assessment of Interoceptive Awareness version 2 [MAIA-2] questionnaire).

EXPLORATORY OBJECTIVES:

I. Assess the effects of exercise vs. standard care on other common symptoms related to cancer, chemotherapy, and CIPN, including:

Ia. Daily Diary of symptoms of CIPN. Ib. An array of cancer and treatment symptoms (MD Anderson Symptom Inventory; MDASI).

Ic. Anxiety and depression (hospital anxiety and depression scale; HADS). Id. Pain catastrophizing (pain catastrophizing scale; PCS). Ie. Cognitive impairment (Functional Assessment of Cancer Therapy-Cognitive [FACT-Cog]).

If. Fatigue (brief fatigue inventory; BFI). Ig. Quality of life (Functional Assessment of Cancer Therapy - General [FACT-G]).

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM 1 (EXERCISE): Participants undergo the exercise for cancer patients (EXCAP) intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5.

ARM 2 (CONTROL): Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes.

Participants may optionally undergo magnetic resonance imaging (MRI) on study.

Tipo de estudio

Intervencionista

Inscripción (Actual)

133

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • California
      • Fresno, California, Estados Unidos, 93720
        • Kaiser Permanente-Fresno
      • Martinez, California, Estados Unidos, 94553-3156
        • Contra Costa Regional Medical Center
      • Roseville, California, Estados Unidos, 95661
        • Kaiser Permanente-Roseville
      • Sacramento, California, Estados Unidos, 95814
        • Kaiser Permanente Downtown Commons
      • Sacramento, California, Estados Unidos, 95823
        • Kaiser Permanente-South Sacramento
      • San Jose, California, Estados Unidos, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Leandro, California, Estados Unidos, 94577
        • Kaiser Permanente San Leandro
      • San Rafael, California, Estados Unidos, 94903
        • Kaiser San Rafael-Gallinas
      • Santa Clara, California, Estados Unidos, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • South San Francisco, California, Estados Unidos, 94080
        • Kaiser Permanente-South San Francisco
      • Vallejo, California, Estados Unidos, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Estados Unidos, 94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora, Colorado, Estados Unidos, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Boulder, Colorado, Estados Unidos, 80303
        • Boulder Community Foothills Hospital
      • Boulder, Colorado, Estados Unidos, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Centennial, Colorado, Estados Unidos, 80112
        • Rocky Mountain Cancer Centers - Centennial
      • Denver, Colorado, Estados Unidos, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Estados Unidos, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Estados Unidos, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, Estados Unidos, 80209
        • The Women's Imaging Center
      • Englewood, Colorado, Estados Unidos, 80113
        • Rocky Mountain Cancer Centers - Swedish
      • Englewood, Colorado, Estados Unidos, 80113
        • The Melanoma and Skin Cancer Institute
      • Lakewood, Colorado, Estados Unidos, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Littleton, Colorado, Estados Unidos, 80120
        • Rocky Mountain Cancer Centers-Littleton
      • Lone Tree, Colorado, Estados Unidos, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, Estados Unidos, 80501
        • Rocky Mountain Cancer Centers-Longmont
      • Thornton, Colorado, Estados Unidos, 80260
        • Rocky Mountain Cancer Centers-Thornton
    • Delaware
      • Millville, Delaware, Estados Unidos, 19967
        • Beebe South Coastal Health Campus
      • Newark, Delaware, Estados Unidos, 19713
        • Helen F Graham Cancer Center
      • Newark, Delaware, Estados Unidos, 19713
        • Medical Oncology Hematology Consultants PA
      • Rehoboth Beach, Delaware, Estados Unidos, 19971
        • Beebe Health Campus
    • District of Columbia
      • Washington D.C., District of Columbia, Estados Unidos, 20010
        • MedStar Washington Hospital Center
      • Washington D.C., District of Columbia, Estados Unidos, 20007
        • MedStar Georgetown University Hospital
    • Hawaii
      • Honolulu, Hawaii, Estados Unidos, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu, Hawaii, Estados Unidos, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, Estados Unidos, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, Estados Unidos, 96826
        • Kapiolani Medical Center for Women and Children
      • ‘Aiea, Hawaii, Estados Unidos, 96701
        • Hawaii Cancer Care - Westridge
      • ‘Aiea, Hawaii, Estados Unidos, 96701
        • Pali Momi Medical Center
    • Illinois
      • Carterville, Illinois, Estados Unidos, 62918
        • SIH Cancer Institute
      • Centralia, Illinois, Estados Unidos, 62801
        • Centralia Oncology Clinic
      • Danville, Illinois, Estados Unidos, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Estados Unidos, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Estados Unidos, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Effingham, Illinois, Estados Unidos, 62401
        • Crossroads Cancer Center
      • O'Fallon, Illinois, Estados Unidos, 62269
        • Cancer Care Center of O'Fallon
      • Urbana, Illinois, Estados Unidos, 61801
        • Carle Cancer Center
    • Iowa
      • Cedar Rapids, Iowa, Estados Unidos, 52403
        • Oncology Associates at Mercy Medical Center
      • Cedar Rapids, Iowa, Estados Unidos, 52402
        • Physicians' Clinic of Iowa PC
      • Des Moines, Iowa, Estados Unidos, 50314
        • Mercy Medical Center - Des Moines
    • Maryland
      • Elkton, Maryland, Estados Unidos, 21921
        • Christiana Care - Union Hospital
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Brighton, Michigan, Estados Unidos, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, Estados Unidos, 48114
        • Trinity Health Medical Center - Brighton
      • Canton, Michigan, Estados Unidos, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, Estados Unidos, 48188
        • Trinity Health Medical Center - Canton
      • Chelsea, Michigan, Estados Unidos, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, Estados Unidos, 48118
        • Chelsea Hospital
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Lansing, Michigan, Estados Unidos, 48912
        • University of Michigan Health - Sparrow Lansing
      • Livonia, Michigan, Estados Unidos, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Ypsilanti, Michigan, Estados Unidos, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
    • Minnesota
      • Coon Rapids, Minnesota, Estados Unidos, 55433
        • Mercy Hospital
      • Fridley, Minnesota, Estados Unidos, 55432
        • Unity Hospital
      • Minneapolis, Minnesota, Estados Unidos, 55407
        • Abbott-Northwestern Hospital
      • Saint Louis Park, Minnesota, Estados Unidos, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul, Minnesota, Estados Unidos, 55101
        • Regions Hospital
      • Waconia, Minnesota, Estados Unidos, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, Estados Unidos, 56201
        • Rice Memorial Hospital
    • Missouri
      • Osage Beach, Missouri, Estados Unidos, 65065
        • Lake Regional Hospital
      • St Louis, Missouri, Estados Unidos, 63131
        • Missouri Baptist Medical Center
    • North Carolina
      • Gastonia, North Carolina, Estados Unidos, 28054
        • CaroMont Regional Medical Center
      • Lincolnton, North Carolina, Estados Unidos, 28092
        • CaroMont Health - Lincoln Cancer Center
      • Pinehurst, North Carolina, Estados Unidos, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Rocky Mount, North Carolina, Estados Unidos, 27804
        • Nash UNC HealthCare
    • Ohio
      • Belpre, Ohio, Estados Unidos, 45714
        • Strecker Cancer Center-Belpre
      • Lancaster, Ohio, Estados Unidos, 43130
        • Fairfield Medical Center
      • Lima, Ohio, Estados Unidos, 45801
        • Saint Rita's Medical Center
      • Marietta, Ohio, Estados Unidos, 45750
        • Marietta Memorial Hospital
      • Newark, Ohio, Estados Unidos, 43055
        • Licking Memorial Hospital
      • Portsmouth, Ohio, Estados Unidos, 45662
        • Southern Ohio Medical Center
      • Zanesville, Ohio, Estados Unidos, 43701
        • Genesis Healthcare System Cancer Care Center
    • South Carolina
      • Boiling Springs, South Carolina, Estados Unidos, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Easley, South Carolina, Estados Unidos, 29640
        • Prisma Health Cancer Institute - Easley
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Estados Unidos, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greer, South Carolina, Estados Unidos, 29650
        • Prisma Health Cancer Institute - Greer
      • Seneca, South Carolina, Estados Unidos, 29672
        • Prisma Health Cancer Institute - Seneca
    • Virginia
      • Chesapeake, Virginia, Estados Unidos, 23320
        • Chesapeake Regional Medical Center
    • Wisconsin
      • Green Bay, Wisconsin, Estados Unidos, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Green Bay, Wisconsin, Estados Unidos, 54303
        • Saint Vincent Hospital Cancer Center at Saint Mary's
      • Sturgeon Bay, Wisconsin, Estados Unidos, 54235-1495
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Have a diagnosis of cancer
  • Have received neurotoxic chemotherapy within the past nine months (could still be on chemotherapy or have already completed chemotherapy; i.e., taxane-, platinum-, vinca alkaloid-, epothilone-, or proteasome inhibitor-based chemotherapy
  • Report one or more symptoms of CIPN at a level of >= 4 on the CIPN symptom inventory on the Screening Form
  • Have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1
  • Have at least six months life expectancy
  • Be at least 18 years of age
  • Be able to read and understand English
  • Be able to provide written informed consent

Exclusion Criteria:

  • Have physical limitations (e.g., cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking and progressive resistance exercise program, according to the participant's physician (e.g., oncologist, primary care) or physician's designee
  • Be identified as in the active or maintenance stage of exercise behavior per the Exercise Stages of Change Question on the Screening Form
  • Have planned surgery or radiation treatment during the course of the study (hormonal and biologic therapy is allowed)
  • Have contraindications for MRI scanning, per the MRI safety screening procedures of the MRI facility to be utilized for this participant
  • Are pregnant of have plans to become pregnant during the course of the study. Documentation of pregnancy and use of contraception can be obtained from the medical record.
  • Have a current or prior cancer in the central nervous system (spine, brainstem, brain) as this would interfere with assessments of brain functional connectivity.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Arm 1 (EXCAP, tactile sensitivity test, counseling)

Participants undergo the EXCAP intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5. Participants may optionally undergo MRI on study.

Undergo MRI

Otros nombres:
  • Resonancia magnética
  • Resonancia magnetica
  • Exploración de imágenes por resonancia magnética
  • Imágenes Médicas, Resonancia Magnética / Resonancia Magnética Nuclear
  • SRES
  • Imágenes de RM
  • Imágenes de RMN
  • RMN
  • Imágenes de resonancia magnética nuclear
  • Imágenes por resonancia magnética (IRM)
  • resonancia magnética nuclear
  • Imágenes por resonancia magnética (procedimiento)
  • Resonancias magnéticas
  • Resonancia magnética estructural

Ancillary studies

Meet with certified exercise instructor

Participate in the EXCAP program

Undergo tactile sensitivity test

Otros nombres:
  • Evaluación para el dolor neuropático
Comparador activo: Arm 2 (usual care, tactile sensitivity test)

Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. Participants may optionally undergo MRI on study.

Undergo MRI

Otros nombres:
  • Resonancia magnética
  • Resonancia magnetica
  • Exploración de imágenes por resonancia magnética
  • Imágenes Médicas, Resonancia Magnética / Resonancia Magnética Nuclear
  • SRES
  • Imágenes de RM
  • Imágenes de RMN
  • RMN
  • Imágenes de resonancia magnética nuclear
  • Imágenes por resonancia magnética (IRM)
  • resonancia magnética nuclear
  • Imágenes por resonancia magnética (procedimiento)
  • Resonancias magnéticas
  • Resonancia magnética estructural

Ancillary studies

Meet with certified exercise instructor

Participate in the EXCAP program

Undergo tactile sensitivity test

Otros nombres:
  • Evaluación para el dolor neuropático

Receive standard of care

Otros nombres:
  • estándar de cuidado
  • terapia estándar

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Chemotherapy-induced peripheral neuropathy (CIPN) symptom severity
Periodo de tiempo: Week 6 post randomization

Will estimate the effects of exercise versus usual care on CIPN using analysis of covariance (ANCOVA). Will be measured by the mean European Organization for Research and Treatment of Cancer-CIPN20. The model will include CIPN-20 at Week 6 as the outcome, treatment group (exercise vs. usual care) as the independent variable of interest and the pre-intervention CIPN-20 score as a covariate.

Week 6 post randomization

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Effects of exercise on the severity of CIPN symptoms
Periodo de tiempo: Up to 6 weeks post randomization

We will estimate the effects of exercise vs. usual care on CIPN symptoms (i.e., hot/burning or sharp/shooting pain in the hands or feet, numbness or tingling in the hands or feet) collected from the daily symptom inventory (0-10 severity) using analysis of covariance (ANCOVA). The model will include the average of daily symptom inventory for each CIPN symptom at post-intervention as the outcome, controlling for the average of daily symptom inventory for each CIPN symptom at pre-intervention.

Up to 6 weeks post randomization
Effects of exercise on tactile sensitivity
Periodo de tiempo: Up to 6 weeks post randomization

We will estimate the effects of exercise vs. usual care on tactile sensitivity in the fingers and toes, assessed via an established touch test procedure with a set of monofilaments, using analysis of covariance (ANCOVA). The model will include the tactile sensitivity score at post-intervention as the outcome, controlling for the pre-intervention score.

Up to 6 weeks post randomization
Effect of exercise on interoception
Periodo de tiempo: Up to 6 weeks post randomization

We will estimate the effects of exercise vs. usual care on interoception, measured via the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2), using analysis of covariance (ANCOVA). The model will include the MAIA-2 total score at post-intervention as the outcome, controlling for the pre-intervention MAIA-2 total score.

Up to 6 weeks post randomization

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Ian R Kleckner, University of Rochester NCORP Research Base

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

25 de febrero de 2022

Finalización primaria (Actual)

23 de abril de 2026

Finalización del estudio (Estimado)

31 de enero de 2027

Fechas de registro del estudio

Enviado por primera vez

11 de mayo de 2021

Primero enviado que cumplió con los criterios de control de calidad

11 de mayo de 2021

Publicado por primera vez (Actual)

17 de mayo de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

29 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

24 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • URCC19075
  • UG1CA189961 (Subvención/contrato del NIH de EE. UU.)
  • URCC19075 (Otro identificador: University of Rochester NCORP Research Base)
  • NCI-2020-11456 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
  • URCC-19075 (Otro identificador: CTEP)
  • R21CA256154 (Subvención/contrato del NIH de EE. UU.)
  • URCC-19075 (Otro identificador: DCP)

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .